| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $16.7M | +7.5% |
| Cost of Revenue | $8.2M | -2.9% |
| Gross Profit | $8.5M | +19.9% |
| R&D Expense | $53.0M | +15.8% |
| SG&A Expense | $59.0M | +0.7% |
| Operating Income | -$103.5M | -6.4% |
| Income Tax | $0 | — |
| Net Income | -$86.3M | +7.2% |
| EPS (Basic) | -$1.35 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.5M | -38.9% |
| Inventory | $4.5M | -2.9% |
| Current Assets | $330.5M | -24.0% |
| Total Assets | $436.3M | -10.6% |
| Current Liabilities | $13.2M | +5.1% |
| Total Liabilities | $39.4M | -3.8% |
| Stockholders' Equity | $396.9M | -11.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$59.1M | +2.8% |
| Capital Expenditures | $7.3M | -28.8% |
| Investing Cash Flow | $37.9M | +130.9% |
| Financing Cash Flow | $452K | -88.4% |
| Free Cash Flow | -$66.4M | +6.6% |
| +9.4% |
| EPS (Diluted) | -$1.35 | +9.4% |